Cardiovascular Systems Inc (CSII) - Medical Equipment - Deals and Alliances Profile
October 2018
40
About the Report
About the Report
Summary
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.
Cardiovascular Systems Inc (CSII)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Cardiovascular Systems Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Inc, Medical Equipment, Deal Details 10
Partnerships 10
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Equity Offering 14
Cardiovascular Systems Completes Public Offering Of Shares For USD 101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For USD 40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For USD 16 Million 17
Cardiovascular Systems Inc-Key Competitors 19
Cardiovascular Systems Inc-Key Employees 20
Cardiovascular Systems Inc-Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Jul 30, 2018: Cardiovascular Systems Reports Fiscal 2018 Fourth-Quarter Financial Results 22
May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results 24
Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 26
Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 28
Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 30
May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 32
Jan 25, 2017: Cardiovascular Systems Reports Fiscal 2017 Second-Quarter Financial Results 34
Corporate Communications 36
Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 36
Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 37
Feb 21, 2017: Cardiovascular Systems Announces Healthcare Veteran Martha Goldberg Aronson Joins Board of Directors 38
Other Significant Developments 39
Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Figure
List of Figures
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Cardiovascular Systems Inc, Medical Equipment, Key Facts, 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cardiovascular Systems Inc, Deals By Market, 2012 to YTD 2018 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cardiovascular Systems Enters into Co-Development Agreement with Aerolase 10
Cardiovascular Systems Enters into Distribution Agreement with OrbusNeich 11
Cardiovascular Systems Enters into Agreement with OrbusNeich 12
Cardiovascular Systems Enters into Distribution Agreement with Medikit 13
Cardiovascular Systems Completes Public Offering Of Shares For USD 101.7 Million 14
Cardiovascular Systems Completes Public Offering Of Shares For USD 40.5 Million 16
Cardiovascular Systems Completes Public Offering Of Common Stock For USD 16 Million 17
Cardiovascular Systems Inc, Key Competitors 19
Cardiovascular Systems Inc, Key Employees 20
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.